Navigation Links
InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia
Date:10/1/2007

Country's Largest Distributors and Pharmacy Chains to Carry RESPeRATE

Hypertension Treatment Device

NEW YORK and MAROOCHYDORE, Australia, Oct. 1 /PRNewswire/ -- InterCure, Ltd. (TASE: INCR), today announced that its RESPeRATE(R) hypertension treatment device, clinically-proven in 10 published studies to significantly lower blood pressure, will launch into retail distribution in Australia through its local marketing and distribution partner, High Tech Health (HTH). RESPeRATE will be distributed through Australia's three largest pharmacy wholesalers into leading pharmacy chains nationwide, including Chemmart, Terry White and Think Pharmacy. This retail distribution partnership marks another key step in RESPeRATE's channel evolution, as it expands from a direct-to- consumer model to more traditional pharmacy channels globally.

High Tech Health will initially introduce RESPeRATE into 300 retail pharmacy locations in early Q4. HTH will leverage its network of merchandising specialists to ensure that each pharmacy staff person is well-trained in the use and benefits of RESPeRATE, to establish merchandising programs at the store level and to hold community patient education sessions on hypertension management and the use of RESPeRATE. HTH currently serves about 1,000 of the 5,000 pharmacies in Australia.

"This is great news for the millions of hypertension sufferers in Australia who seek a new option to help control their condition," said Erez Gavish, president and CEO of InterCure. "The vast majority of our prospective customers tell us that they would prefer to buy RESPeRATE at their local pharmacy. Our move into the Australian pharmacy channel will allow consumers to buy at their preferred retailer for health products, while building a strong retail presence for InterCure. This marks another key step in the Company's broad strategy of adding pharmacy distribution to our direct sales platform."

Almost one billion pe
'/>"/>

SOURCE InterCure, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Startling Expose – Physicians Often Have No Regular Source Of Health Car
3. Debate Rages over firing of HIV infected health care workers
4. Want a Healthy brew? Have some Tea!
5. Patient’s perception of health status helps in better recover
6. Antioxidants protect health tissue in people undergoing radiation therapy.
7. Sexual abuse affect health for a lifetime
8. Smoking a greater risk than HIV? Yes say health experts!!!!
9. Healthcare sector is now a multi billion-dollar industry in India
10. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
11. How much can exercise improve health?
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Coronary angiography may improve outcomes for cardiac arrest patients 2Health News:Coronary angiography may improve outcomes for cardiac arrest patients 3Health News:Pennsylvania Dental Association Cautions Patients: Don't Forgo Dental Visits Because of the Economy 2Health News:NASDAQ Gives Dynatronics a Third Three-Month Extension for Minimum Bid Price Compliance 2Health News:Researchers question effectiveness of warning labels on over-the-counter drugs 2Health News:Researchers question effectiveness of warning labels on over-the-counter drugs 3Health News:CSHL neuroscientists propose project to comprehensively map mammalian brain circuits 2Health News:CSHL neuroscientists propose project to comprehensively map mammalian brain circuits 3Health News:CSHL neuroscientists propose project to comprehensively map mammalian brain circuits 4Health News:CSHL neuroscientists propose project to comprehensively map mammalian brain circuits 5Health News:Male Cosmetic Surgery Slows Down While Female Cosmetic Surgery Advances 2
Breaking Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 1Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 2Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 3MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 1MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 2MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 3MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 4MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 5Association found between Parkinsons disease and pesticide exposure in French farm workers 47972 1Association found between Parkinsons disease and pesticide exposure in French farm workers 47972 2
Other Medicine Technology:New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 2New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 3New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 4New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 5New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 6Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 2Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 3Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 4Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 5Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 6Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 7Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 8Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 9Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 10Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 11Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 12Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 13